Policies for the immunization against serogroup B meningococcus for adolescents immunized during the first two years of life: A mini review
Two vaccines are available to prevent serogroup B meningococcal disease, i.e. the four-component meningococcal serogroup B vaccine (4CMenB) and the bivalent-factor-H-binding-protein meningococcal serogroup B vaccine (MenB-fHbp). Currently, 4CMenB is offered as part of routine infant immunization sch...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Taylor & Francis Group
2024-12-01
|
| Serier: | Human Vaccines & Immunotherapeutics |
| Fag: | |
| Online adgang: | https://www.tandfonline.com/doi/10.1080/21645515.2024.2396220 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
